Citation 80476

KERNAN,MR: AMARQUAVE,A: CHEN,JL: CHAN,J: SESIN,DF: PARKINSON,N: YE,ZJ: BARRETT,M: BALES,C: STODDART,CA: SLOAN,B: BLANC,P: LIMBACH,C: MRISHO,S: ROZHON,EJ:. (1998). ANTIVIRAL PHENYLPROPANOID GLYCOSIDES FROM THE MEDICINAL PLANT MARKHAMIA LUTEA.. 61(5)

Citation Details

TitleANTIVIRAL PHENYLPROPANOID GLYCOSIDES FROM THE MEDICINAL PLANT MARKHAMIA LUTEA.
AuthorsKERNAN,MR: AMARQUAVE,A: CHEN,JL: CHAN,J: SESIN,DF: PARKINSON,N: YE,ZJ: BARRETT,M: BALES,C: STODDART,CA: SLOAN,B: BLANC,P: LIMBACH,C: MRISHO,S: ROZHON,EJ:
Year1998
Volume61
Issue5

Summary

Year: 1998

Journal: Unknown

Organisms and Their Experiments (1)

Markhamia lutea (BIGNONIACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
VERBASCOSIDE
None
2
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
VERBASCOSIDE
WEAK ACTIVITY
3
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
VERBASCOSIDE
WEAK ACTIVITY
4
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
VERBASCOSIDE
WEAK ACTIVITY
5Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
VERBASCOSIDE,ISO:
None
6
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
VERBASCOSIDE,ISO:
WEAK ACTIVITY
7
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
VERBASCOSIDE,ISO:
WEAK ACTIVITY
8
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
VERBASCOSIDE,ISO:
WEAK ACTIVITY
9
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
VERBASCOSIDE,ISO:
WEAK ACTIVITY
10
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
VERBASCOSIDE,ISO:
WEAK ACTIVITY
11Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
LUTEOSIDE A
None
12
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LUTEOSIDE A
WEAK ACTIVITY
13Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
LUTEOSIDE B
None
14
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LUTEOSIDE B
WEAK ACTIVITY
15
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LUTEOSIDE B
WEAK ACTIVITY
16
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LUTEOSIDE B
WEAK ACTIVITY
17Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
LUTEOSIDE C
None
18
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LUTEOSIDE C
INACTIVE
Show SPARQL Queries (1)